Our Story
ORIGINS & FOUNDATION
Built on Deep Pharmaceutical Expertise
- Oxeltis was founded in 2010 by former researchers from Idenix Pharmaceuticals in Montpellier, France. Born from deep pharmaceutical expertise, the company was built on a single conviction: that sound and robust organic chemistry, rigorously executed, is the cornerstone of successful drug discovery.
CORE COMPETENCIES
Mastery of Complex Organic Synthesis
-
From the outset, Oxeltis focused on complex organic synthesis, developing recognized expertise in heterocycles, macrocycles, nucleosides, and phosphoramidites chemistry.
The kind of difficult, high-value chemistry that demands both scientific excellence and operational precision.
GLOBAL REACH & QUALITY
15+ Years of International Trust
- That commitment has never wavered since 2010. Tackling some of the most challenging projects in drug discovery and complex synthesis, Oxeltis earned the trust of biotech and pharma clients across Europe, North America, and Japan, along with the ISO 9001 accreditation to back it.
STRATEGIC EVOLUTION
Delivering Fully Integrated Drug Discovery
- Oxeltis now leads an integrated drug discovery consortium. Alongside Molecular Forecaster (computational design and AI), Partex.AI Labs (in vitro screening and pharmacology) and GenEvolutioN (early mutagenicity screening), Oxeltis offers the client a single point of contact from hit identification to candidate selection. Design, synthesis and testing are coordinated within one fast, data-driven cycle.
Our Services
Tailored solutions designed to accelerate and secure your projects.
Our Expertise
Specialized technical know-how to tackle your complex challenges.